HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 202 filers reported holding HEALTH CATALYST INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,778 | -97.5% | 1,065 | -96.9% | 0.00% | – |
Q2 2023 | $431,776 | +2329.4% | 34,542 | +2168.0% | 0.00% | – |
Q1 2023 | $17,773 | +0.6% | 1,523 | -8.4% | 0.00% | – |
Q4 2022 | $17,667 | -36.9% | 1,662 | -41.9% | 0.00% | – |
Q3 2022 | $28,000 | -72.0% | 2,862 | -58.5% | 0.00% | – |
Q2 2022 | $100,000 | -89.4% | 6,899 | -80.9% | 0.00% | -100.0% |
Q1 2022 | $943,000 | +57.7% | 36,071 | +138.9% | 0.00% | – |
Q4 2021 | $598,000 | +60.8% | 15,098 | +102.8% | 0.00% | – |
Q3 2021 | $372,000 | -87.0% | 7,446 | -85.6% | 0.00% | -100.0% |
Q2 2021 | $2,870,000 | +1443.0% | 51,702 | +1196.8% | 0.00% | – |
Q1 2021 | $186,000 | -38.2% | 3,987 | -42.4% | 0.00% | – |
Q4 2020 | $301,000 | +356.1% | 6,919 | +284.2% | 0.00% | – |
Q3 2020 | $66,000 | -67.6% | 1,801 | -74.3% | 0.00% | – |
Q2 2020 | $204,000 | +32.5% | 7,010 | +18.9% | 0.00% | – |
Q1 2020 | $154,000 | +120.0% | 5,897 | +192.7% | 0.00% | – |
Q4 2019 | $70,000 | +536.4% | 2,015 | +438.8% | 0.00% | – |
Q3 2019 | $11,000 | – | 374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |